Apologies, when I said ResAppDx I meant the algorithm (I've done this in the past as well).
"ResApp has developed smartphone-based machine learning algorithms that have been found in a prospective clinical study to accurately identify acute exacerbations in patients with asthma or COPD. ResApp also has ongoing clinical programs investigating the use of these techniques to measure exacerbation severity and lung function."
Ann: Proposed issue of Securities - RSH, page-189
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.54M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 800000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 508500 | 3 |
View Market Depth
| Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable